Top Banner
Medication management of Behavioral Problems in Patients with End Stage Dementia
21

Medication management of Behavioral Problems in Patients with End Stage Dementia.

Dec 22, 2015

Download

Documents

Theodore Cain
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Medication management of Behavioral Problems in Patients with End Stage Dementia.

Medication management of Behavioral Problems in Patients with End Stage Dementia

Page 2: Medication management of Behavioral Problems in Patients with End Stage Dementia.

Clinical Features in Late Stage Dementia Alzheimer's – Delusions, agitation Frontotemporal - Personality changes,

disinhibition, Impulsivity Lewy Body – Visual Hallucinations, Falls,

Syncope, Sensitivity to Antipsychotic Meds

Vascular – Abrupt onset, stepwise, prominent aphasia, severe depression

Page 3: Medication management of Behavioral Problems in Patients with End Stage Dementia.

Partnership Crucial to form a partnership with family

and caregivers Neuropsychiatric Inventory and

Behavioral Pathology for Alzheimer Disease – standardized measures for assessing behavioral disturbances

Page 4: Medication management of Behavioral Problems in Patients with End Stage Dementia.

Behaviors – Distress related Falls, wandering, repetitive questions,

physical and verbal aggression, resisting cares, alterations in sleep, agitation, delusions, hallucinations

Educate caregivers that some behaviors don’t respond to pharmaceuticals : wandering, rummaging, repetitive questions, calling out

Page 5: Medication management of Behavioral Problems in Patients with End Stage Dementia.

Environmental Triggers Lack of social interaction Sensory overstimulation Crowded areas Large spaces Moves

Page 6: Medication management of Behavioral Problems in Patients with End Stage Dementia.

Assessment Copy of History and Physical Labs: CBC with platelets, CMP, UA, B12,

Folate, Vitamin D3, TSH, Free T4 Patient’s Med List History of underlying psychiatric illness Social History (abuse) Course of dementia POOP, PEE PAIN

Page 7: Medication management of Behavioral Problems in Patients with End Stage Dementia.

Questions I ask the caregivers Course of dementia? Recent medical/drug changes – exacerbation of

chronic disease Sleep? Eat? Weight Loss? Do they ever say they want to die? Tearful? Delusions (stealing from them, poisoning them)? Hallucinations (talking to people not there,

visual)? Worse in the afternoon – Sundowning?

Page 8: Medication management of Behavioral Problems in Patients with End Stage Dementia.

Delirium Acute Onset Inattention Disorganized thinking or Altered Level of

consciousness

Page 9: Medication management of Behavioral Problems in Patients with End Stage Dementia.

Commonly used Drugs with Anticholinergic effects which can increase confusion

Benadryl – (tylenol sleep) Bladder antispasmodics – oxybutynin Tricyclic antidepressants SNRIs (cymbalta, effexor xr) Paxil! Olanzapine (Zyprexa) Muscle Relaxants – flexeril Lasix

Page 10: Medication management of Behavioral Problems in Patients with End Stage Dementia.

Other drugs which cause confusion and possibly delirium in the elderly Benzodiazepines! Gabapentin Lasix Parkinson drugs – sinemet, requip,

miralax Opiates, other pain meds ANY DRUGS

Page 11: Medication management of Behavioral Problems in Patients with End Stage Dementia.

Drugs with and indication for managing behavioral disturbances in dementia

NONE

Page 12: Medication management of Behavioral Problems in Patients with End Stage Dementia.

Categories of Medications used to treat - all off label Antidepressants Mood stabilizers Antipsychotics Benzodiazepines Cognitive enhancers -

Anticholinesterase inhibitors, Namenda

Page 13: Medication management of Behavioral Problems in Patients with End Stage Dementia.

SIG Routine is usually better than prn

Page 14: Medication management of Behavioral Problems in Patients with End Stage Dementia.

Antidepressants SSRIs – Celexa (Citalopram) up to 20mg Lexapro – up to 10mg Zoloft – up to 100mgNOT – Paxil or ProzacNOT - Tricyclic'sSNRIs – Remeron start with 15mg, Cymbalta, Effexor - rarelyWellbutrin XL – morning dose

Page 15: Medication management of Behavioral Problems in Patients with End Stage Dementia.

Serotonin syndrome Potentially fatal, Begins in hours after

new medication Confusion Alterations in blood pressure and/or

temperature Rapid heart rate Shivering Twitching

Page 16: Medication management of Behavioral Problems in Patients with End Stage Dementia.

Mood Stabilizers Depakote – usually sprinkles – up to 500mg

divided BID or TID - not much evidence ?(underlying seizure/bipolar)

Tegretol - some evidence Levels not accurate in elderly although

required by Medicare, monitor platelets and LFTs

Lamictal – Fast spreading rash (underlying seizure/bipolar)

NOT LITHIUM

Page 17: Medication management of Behavioral Problems in Patients with End Stage Dementia.

Black Box Warning Elderly patients with dementia related

psychosis treated with an antipsychotic drug are at an increased risk of death – they are not approved for the treatment of dementia related psychosis

Three fold greater risk of thrombolytic complications when used for dementia related behaviors

Page 18: Medication management of Behavioral Problems in Patients with End Stage Dementia.

Antipsychotics Risperdal – 0.25-2mg (ODT) Seroquel – 50-200mg Zyprexa – 2.5- 10mg (ODT)

Abilify, Geodon, Latuda, Saphris, Fanapt Improvement in patients with psychosis

and global neuropsychiatric disturbance

Page 19: Medication management of Behavioral Problems in Patients with End Stage Dementia.

Comparative Risk of antipsychotics

Retrospective study of a large cohort of elderly veterans with dementia

Death rate per 100 person – years: Haldol - 46 Zyprexa and Risperdal – 27 Seroquel – 19 Am. J Psychiatry 2012; 169:71-9

Page 20: Medication management of Behavioral Problems in Patients with End Stage Dementia.

Cognitive Enhancers Aricept – up to 23 mg (odt) AM dose Razadyne ER – Up to 10 mg - AM Exelon po – UP to 12 mg q day Exelon patch – up to 13.3 q 24 hours

Namenda 10mg bid Side effects: nausea, diarrhea, headaches All have titration schedules Withdraw – taper as appropriate one at a time Sudden taper – rebound confusion and agitation

Page 21: Medication management of Behavioral Problems in Patients with End Stage Dementia.

Benzodiazepine equivalents and half lives- including active metabolites

Xanax 0.5mg – 6-26 hours Ativan – 0.25 10-20 hours Klonipin – 0.25 20-50 hours (.125mg q

day) Valium – 5mg – 20-100 hours Side effects: Falls, increased confusion,

disinhibition Use tiny doses – frequently if necessary